» Articles » PMID: 23214064

[Management of Graves' Ophthalmopathy by Using Orbital Magnetic Resonance Imaging]

Overview
Journal Nihon Rinsho
Specialty General Medicine
Date 2012 Dec 11
PMID 23214064
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Orbital magnetic resonance imaging (MRI) can visualize the inflamed lesions of Graves' ophthalmopathy(GO). Parasagittal, transverse and coronal sections of T1-weighted, T2-weighted and short inversion time inversion recovery(STIR) images correlate clinical manifestations with the location of the inflamed lesions. In addition, the measurement of T2 relaxation time or signal intensity ratio of the enlarged muscles in T2-weighted fat suppression images or STIR images provide a precise quantitative evaluation of disease activity and may predict the outcome of immunosuppressive therapy for GO. Thus, MRI is useful for decision-making regarding immunosuppressive therapy and prompt surgery for GO. Therefore, we recommend MRI as a useful tool for the management of GO in specialized clinics.

Citing Articles

A curative effect evaluation of intensity-modulated radiation therapy combined with periorbital triamcinolone acetonide injection in treating thyroid eye disease patients with active extraocular muscle but low CAS.

Zhang H, He W Sci Rep. 2025; 15(1):3222.

PMID: 39863792 PMC: 11763082. DOI: 10.1038/s41598-025-88142-w.


Use of extreme gradient boosting, light gradient boosting machine, and deep neural networks to evaluate the activity stage of extraocular muscles in thyroid-associated ophthalmopathy.

Li Y, Ma J, Xiao J, Wang Y, He W Graefes Arch Clin Exp Ophthalmol. 2023; 262(1):203-210.

PMID: 37773288 DOI: 10.1007/s00417-023-06256-1.


[Clinical Analysis of 2 170 Cases of Thyroid-Associated Ophthalmopathy Involving Extraocular Muscles].

Yang M, Du B, Wang Y, He W Sichuan Da Xue Xue Bao Yi Xue Ban. 2021; 52(3):510-515.

PMID: 34018373 PMC: 10409202. DOI: 10.12182/20210560507.


Prevalence of Radiological Signs of Dysthyroid Optic Neuropathy in Magnetic Resonance Imaging in Patients with Active, Moderate-to-Severe, and Very Severe Graves Orbitopathy.

Rutkowska-Hinc B, Maj E, Jablonska A, Milczarek-Banach J, Bednarczuk T, Miskiewicz P Eur Thyroid J. 2018; 7(2):88-94.

PMID: 29594060 PMC: 5869563. DOI: 10.1159/000486828.